Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Détails bibliographiques
Auteur principal:	Zangmo, Thinley
Autres auteurs:	Asaduzzaman, Muhammad
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Lung cancer NF-kB pathway SNP Co-expressed genes Differentially expressed genes Lungs > Cancer > Treatment. Lungs > Cancer > Molecular aspects. Bioinformatics.
Accès en ligne:	http://hdl.handle.net/10361/24297

Documents similaires

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
par: Jeba, Joynob
Publié: (2017)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
par: Shabnam, Musharrat
Publié: (2018)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

Qualitative classification of the breast cancer genome and clustering of the cancer gene network
par: Fatema, Kaniz, et autres
Publié: (2019)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
par: Das, Reshita
Publié: (2024)

A study of glioblastoma gene profile
par: Nabila, Nusrat Jahan
Publié: (2024)

Lung cancer detection and classification using machine learning
par: Arefin, Mahbubul, et autres
Publié: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
par: Beruni, Sajid Mahmud Al
Publié: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
par: Mukti, Roushney Fatima, et autres
Publié: (2016)

A study of Osteosarcoma gene profile
par: Arka, Sadib Md.
Publié: (2022)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
par: Nuha, Nabiha Tahsin
Publié: (2024)

Role of statins as antagonists of SPARC in gastric cancer
par: Shahmat, Rad
Publié: (2019)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
par: Nandy, Aditi
Publié: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
par: Lamia
Publié: (2020)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
par: Shaikat, Mahdi Mubin
Publié: (2023)

To control site-specific skin gene expression, autocrine mimics paracrine canonical Wnt signaling and Is activated ectopically in skin disease
par: Kim, Dongwon, et autres
Publié: (2016)

Oncogenes: new targets in cancer treatment
par: Chowdhury, Waseka Shams
Publié: (2020)

A review on RNAi technology and its therapeutic potential in Cancer
par: Mahaleka, Aarshi
Publié: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
par: Ahmed, Nafisa
Publié: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
par: Araf, Faiaz Fahim
Publié: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
par: F. S. Amaral, André, et autres
Publié: (2017)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
par: Hasan, Samir, et autres
Publié: (2024)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
par: Auvy, Akib Al Mahmud, et autres
Publié: (2023)

Statistics and informatics in molecular cancer research

A review on potential of PARP inhibitors in the treatment of prostate cancer
par: Islam, Saidul
Publié: (2022)

A review on triple-negative breast cancer and its potential treatment
par: Niasa, Jannatul Ferdous
Publié: (2023)